U.S. Electrical Stock News

NYSE:TRNO
NYSE:TRNOIndustrial REITs

Terreno Realty (TRNO) Lease Momentum Keeps Valuation In Focus

Terreno Realty (TRNO) is back in focus after a series of industrial lease announcements, including early renewals and expansions in New York and California that extend occupancy commitments well into the next decade. See our latest analysis for Terreno Realty. Recent lease wins in New York and California come as Terreno Realty’s share price sits at $72.68, with a 30-day share price return of 11.06% and a 1-year total shareholder return of 31.83%. This suggests momentum has been building over...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

Marten Transport (MRTN) Stock Faces Margin Pressure As Net Profit Slips To 1.5%

Marten Transport (MRTN) opened Q2 2026 with revenue of US$223.5 million and basic EPS of US$0.07, alongside net income of US$5.3 million, setting the tone for how investors will judge its margin profile and earnings power. Over recent quarters, the company has seen revenue move between US$203.5 million and US$229.9 million, while quarterly EPS has ranged from roughly US$0.02 to US$0.09. This provides a mixed backdrop for a stock that is increasingly being assessed on the quality and...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Sandisk (SNDK) Stock Rose As Big Tech Sold Off##

Sandisk (NasdaqGS:SNDK) shares gained ground during a sharp sell off in major tech stocks, diverging from the broader downturn in the Magnificent Seven. The move highlighted renewed interest in memory chip makers as investors reconsidered exposure to the largest tech stocks. Sandisk closed at $1,436.56, with the stock up 6% over the past week and up 421.9% year to date. While mega cap tech stocks saw one of their steepest single day declines in over a year, Sandisk moved in the opposite...
NasdaqGS:STBA
NasdaqGS:STBABanks

S&T Bancorp (STBA) Stock Net Interest Margin Near 4% Supports Bullish Narratives

S&T Bancorp (STBA) has reported another solid quarter, with Q2 2026 revenue of US$104.1 million and basic EPS of US$1.02 supported by net income of US$36.6 million. The trailing twelve months show revenue of US$404.7 million and EPS of US$3.78. Over the past few quarters, revenue has moved from US$98.1 million in Q2 2025 to US$104.1 million in Q2 2026, with basic EPS over that stretch running between US$0.83 and US$1.02, contributing to trailing twelve month net income of US$140.6 million...
NYSE:IMAX
NYSE:IMAXEntertainment

Imax (IMAX) Stock Faces Premium P/E As Q2 EPS Growth Tests Bullish Narrative

IMAX (IMAX) has just posted its Q2 2026 scorecard, with revenue of US$102.8 million and basic EPS of US$0.28, setting the tone for how investors assess the latest quarter. The company has seen quarterly revenue move from US$91.7 million in Q2 2025 to US$102.8 million in Q2 2026, while basic EPS over the same periods shifted from US$0.21 to US$0.28 as IMAX worked this performance into a trailing twelve month net profit margin of 9.8%. This has left investors focused on how durable that...
NasdaqGS:NRIM
NasdaqGS:NRIMBanks

Northrim BanCorp (NRIM) Stock Net Interest Margin At 5.01% Tests Bearish Narratives

Northrim BanCorp (NRIM) opened Q2 2026 with total revenue of US$52.2 million and basic EPS of US$0.69, while trailing twelve month revenue stood at US$215.7 million with EPS of US$3.09, setting a clear earnings season backdrop for investors watching this regional bank. Over recent quarters, the company has seen revenue move from US$48.3 million in Q2 2025 to US$52.2 million in Q2 2026, with quarterly EPS shifting from US$0.53 to US$0.69 over the same period as trailing EPS climbed from...
NYSE:FIX
NYSE:FIXConstruction

Comfort Systems USA (FIX) Stock Faces Rich P/E As EPS Growth Reinforces Bullish Narratives

Comfort Systems USA (FIX) has put up another strong quarter, with Q2 2026 revenue at about US$3.3b and basic EPS of US$12.54, supported by trailing twelve month EPS of US$40.69 on revenue of roughly US$11.2b. The company has seen revenue move from US$2.2b and EPS of US$6.54 in Q2 2025 to US$3.3b and EPS of US$12.54 in Q2 2026, alongside trailing earnings growth of 107.2% over the past year. This sets the stage for margins that look meaningfully stronger heading into this reporting season. See...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Viasat (VSAT) Could Be 24% Below Fair Value After BMW Satellite Call Milestone

Viasat (VSAT) stock is drawing fresh attention after the company reported a first-of-its-kind in-car satellite voice call integrated into BMW Group’s vehicle platform during 5GAA meetings in Munich. See our latest analysis for Viasat. At a share price of $71.70, Viasat has given investors a 30 day share price return of 15.22% and a year to date share price return of 90.54%, while the 1 year total shareholder return of 388.09% points to strong momentum that contrasts with the recent 1 day...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase (COIN) Appoints Dominique Baillet As Chief People Officer After Lawrence Brock Steps Down

Coinbase Global (NasdaqGS:COIN) announced a Chief People Officer transition as Lawrence Brock steps down. Dominique Baillet is set to assume the Chief People Officer role, with a succession and advisory arrangement in place. The change affects a core leadership position during a period of growth and international expansion for Coinbase Global. Coinbase Global enters this leadership transition with its shares trading at $158.29 and a mixed return profile. The stock is up 0.7% over the past...
NYSEAM:ACU
NYSEAM:ACUMedical Equipment

Acme United (ACU) Stock Q2 EPS Rebound Undermines “Steady Essentials” Narrative

Acme United (ACU) just posted Q2 2026 results with revenue of US$62.7 million and net income of US$5.1 million, translating into EPS of US$1.32. The company reported revenue of US$54.0 million in Q2 2025 and US$62.7 million in Q2 2026, while EPS shifted from US$1.26 to US$1.32 over the same period, giving investors fresh data points on how the top and bottom lines are tracking. With margins in focus this quarter, the results give shareholders a clearer view of how efficiently the company is...
NasdaqGS:WRLD
NasdaqGS:WRLDConsumer Finance

World Acceptance (WRLD) Stock Faces Margin Slide That Reinforces Bearish Narratives

World Acceptance (WRLD) has just opened its Q1 2027 season with trailing financials that frame a mixed picture, with the latest full quarter showing Q4 2026 revenue of US$176.6 million and Basic EPS of US$7.61 alongside net income of US$36.1 million. Over recent periods, revenue has ranged from US$132.5 million to US$176.6 million per quarter, while Basic EPS has swung between a loss of US$0.38 in Q2 2026 and a gain of US$8.04 in Q4 2025. This gives investors a clear view of how quickly...
NYSE:BYD
NYSE:BYDHospitality

Boyd Gaming (BYD) Stock Confronts One Off Driven 44% Net Margin After Q2 Earnings

Boyd Gaming (BYD) has just posted Q2 2026 results with revenue of US$1.0 billion, basic EPS of US$1.75 and trailing 12 month EPS of US$23.37, all against a backdrop of earnings that have risen very sharply over the past year on the back of a large one off gain. The company has seen quarterly revenue move in a tight band between US$991.6 million and US$1.1 billion over the past six reported quarters, while quarterly EPS has ranged from US$1.31 to an outlier of US$17.81. This has fed into...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Atlanticus Holdings (ATLC) Stock Looks Like A Bargain As Earnings Hold The Key

Atlanticus Holdings has delivered a strong share price run over the last few years, yet the broader valuation checks currently lean more expensive than cheap. This creates a tension for anyone trying to judge whether the stock still offers value at around US$99.48. Atlanticus Holdings has returned about 148.6% over the past 3 years, which puts recent short term pullbacks into the context of a sizeable multi year gain. The company’s valuation can be influenced by how consistently it turns...
NYSE:BDN
NYSE:BDNOffice REITs

Brandywine Realty Trust (BDN) Stock Sees Q2 FFO Hold Near 24 Million As Narratives Diverge

Brandywine Realty Trust (NYSE:BDN) opened Q2 2026 with total revenue of US$120.2 million, a basic EPS loss of US$0.18, and net income loss of US$31.7 million, with funds from operations (FFO) at US$23.6 million. These metrics are helping to shape how this quarter is being judged. Over the past few quarters, the company has reported revenue of US$105.3 million in Q2 2025, US$110.8 million in Q4 2025, and US$118.2 million in Q1 2026, while quarterly basic EPS losses ranged between US$0.15 and...
NYSE:VNT
NYSE:VNTElectronic

Vontier (VNT) Draws Fresh Investor Interest, Is It Still 18% Undervalued?

Vontier (VNT) is back on investors’ radar after Rewey Asset Management disclosed a new position, following a share price pullback tied to reduced revenue guidance and the planned Teletrac Navman divestiture. See our latest analysis for Vontier. At a latest share price of US$30.78, Vontier’s recent 1 day and 7 day share price returns in the low single digits sit against a 90 day share price decline of about 15% and a 1 year total shareholder return decline of about 22%. This suggests short...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Stock Faces Margin Hit As One Off Loss Tests Bullish Narratives

Edwards Lifesciences (EW) has reported Q2 2026 results with total revenue of US$1,741 million and basic EPS of US$0.42, while trailing twelve month revenue stands at US$6.5 billion with EPS of US$1.69 as the company works through a period of softer profitability. The company has seen quarterly revenue move from US$1,532 million in Q2 2025 to US$1,741 million in Q2 2026, with basic EPS shifting from US$0.58 to US$0.42 over the same period as trailing net margin compressed from 24.8% to 15% and...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Did Inter’s New Battery-Free Payment Wearables Just Shift Inter & Co's (INTR) Investment Narrative?

Earlier in July 2026, Inter announced the U.S. launch of its battery-free Inter Ring and Inter Wristband, passive NFC wearables that extend customers’ existing Inter credit cards for secure, contactless payments managed via the Inter App. This move signals Inter’s push to deepen everyday payment engagement with U.S. customers by embedding its card offering into simple, screenless wearables that fit seamlessly into daily life. Next, we’ll examine how extending Inter’s credit cards into...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Is Upbound Group (UPBD) A Bargain Following Its Recent Share Price Pullback?

Upbound Group (UPBD) stock is in focus after recent performance data showed mixed returns across different periods. This is raising fresh questions about how investors should view its value, risk, and underlying business trends. See our latest analysis for Upbound Group. At a share price of US$20.46, Upbound Group has recently pulled back, with the 1-day share price return down 2.94% and the 7-day share price return down 7.67%. This comes even though the year-to-date share price return of...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Should Applied Optoelectronics’ Pearland Capacity Expansion Reshape AAOI’s AI Infrastructure Investment Narrative?

Applied Optoelectronics, Inc. has begun construction on two adjacent facilities in Pearland, Texas, adding nearly 400,000 square feet of manufacturing capacity to expand production of its 800G and 1.6T optical transceivers for AI and cloud infrastructure. This expansion deepens the company’s Houston-area footprint while tapping Pearland’s workforce and infrastructure to support its long-term plan to scale advanced optical transceiver manufacturing for data-intensive applications. Next, we’ll...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

First Bancorp (FBNC) Stock Faces Stability Test As Net Interest Margin Narrative Meets Q2 Results

First Bancorp (FBNC) opened Q2 2026 with total revenue of US$126.1 million and basic EPS of US$1.22, set against trailing twelve month EPS of US$3.22 as earnings over the past year grew 37.1% and net profit margin reached 32.3%. Over recent quarters the company has seen revenue move from US$104.7 million in Q1 2025 to US$126.1 million in Q2 2026, alongside quarterly EPS rising from US$0.88 to US$1.22. This frames the latest update against a clear upward earnings trend. With net interest...
NYSE:EQBK
NYSE:EQBKBanks

Equity Bancshares (EQBK) Could Be 3% Undervalued On Strong Q2 Earnings

Equity Bancshares (EQBK) is back in focus after second quarter 2026 results, as the bank reported $73.87 million in net interest income, $26.44 million in net income, and $1.7 million in net charge offs. See our latest analysis for Equity Bancshares. The latest results arrive after a solid run in Equity Bancshares' stock, with a 12.13% year to date share price return and a 33.23% total shareholder return over the past year. The recent buyback and second quarter earnings keep momentum...
NYSE:COTY
NYSE:COTYPersonal Products

Softening Beauty Demand Signals Might Change The Case For Investing In Coty (COTY)

Earlier this week, Coty faced pressure after rival beauty firms Galderma and Medmix reported softening consumer sentiment and weaker demand across key beauty categories, highlighting a tougher sector backdrop. The fact that Coty’s shares reacted to commentary from competitors rather than its own announcements underscores how sensitive the stock is to shifts in wider beauty industry demand expectations. We’ll now explore how this softer consumer backdrop in beauty could influence Coty’s...
NasdaqGS:CALM
NasdaqGS:CALMFood

Cal-Maine Foods (CALM) Reports A Quarterly Loss, Is The Stock Fully Priced?

Cal-Maine Foods (CALM) is back in focus after reporting fourth quarter and full year 2026 results, with quarterly sales of US$552.6 million and a net loss of US$35.9 million. See our latest analysis for Cal-Maine Foods. Despite the weaker fourth quarter, Cal-Maine Foods’ 1 month share price return of 14.3% and 3 month share price return of 18.5% suggest momentum has picked up, even as the 1 year total shareholder return declined 9.4% following a very strong 5 year total shareholder return of...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Does Sustained Alixorexton Data in Narcolepsy Reshape The Bull Case For Alkermes (ALKS)?

Earlier in July 2026, Alkermes reported interim results from its long-term extension study showing alixorexton produced sustained, clinically meaningful improvements in wakefulness, sleepiness, cognition and fatigue for adults with narcolepsy type 1 and 2, with a generally favorable safety profile across dose groups. The data, coupled with US and European regulatory designations and ongoing phase 3 Brilliance trials, underscores alixorexton’s potential to anchor Alkermes’ emerging orexin 2...